Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||International federation of clinical chemistry/international association of therapeutic drug monitoring and clinical toxicology working group on immunosuppressive drug monitoring|
|Citation:||Therapeutic Drug Monitoring, 2002; 24(1):59-67|
|Publisher:||Lippincott Williams & Wilkins|
|David W. Holt, Victor W. Armstrong, Andrea Griesmacher, Raymond G. Morris, Kimberly L. Napoli, and Leslie M. Shaw|
|Abstract:||Issues surrounding the measurement and interpretation of immunosuppressive drug concentrations have been summarized in a number of consensus documents. The Scientific Division of the International Federation of Clinical Chemistry has formed a working group in collaboration with the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. This paper sets out the goals of the working group in light of the developments that have occurred in the field of immunosuppressive drug monitoring since the publication of the last consensus documents.|
|Keywords:||International Federation of Clinical Chemistry; International Association of Therapeutic Drug Monitoring; Clinical Toxicology working group on immunosuppressive drug monitoring; Animals; Humans; Mycophenolic Acid; Sirolimus; Tacrolimus; Cyclosporine; Immunosuppressive Agents; Drug Monitoring; Graft Rejection|
|Appears in Collections:||Pharmacology publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.